A new trading day began on Monday, with Roivant Sciences Ltd (NASDAQ: ROIV) stock price down -2.12% from the previous day of trading, before settling in for the closing price of $11.32. ROIV’s price has ranged from $8.73 to $13.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -397.62%. With a float of $418.04 million, this company’s outstanding shares have now reached $695.94 million.
Let’s determine the extent of company efficiency that accounts for 750 employees. In terms of profitability, gross margin is 92.05%, operating margin of -1340.3%, and the pretax margin is -776.7%.
Roivant Sciences Ltd (ROIV) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Roivant Sciences Ltd is 38.51%, while institutional ownership is 71.21%. The most recent insider transaction that took place on Jun 04 ’25, was worth 6,207,856. In this transaction 10% Owner of this company sold 547,430 shares at a rate of $11.34, taking the stock ownership to the 38,627,181 shares. Before that another transaction happened on Jun 06 ’25, when Company’s 10% Owner sold 200,800 for $11.19, making the entire transaction worth $2,246,952. This insider now owns 38,426,381 shares in total.
Roivant Sciences Ltd (ROIV) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -397.62% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Here are Roivant Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 33.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 98.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Looking closely at Roivant Sciences Ltd (NASDAQ: ROIV), its last 5-days average volume was 5.51 million, which is a drop from its year-to-date volume of 5.72 million. As of the previous 9 days, the stock’s Stochastic %D was 55.58%. Additionally, its Average True Range was 0.34.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 77.30%, which indicates a significant increase from 51.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.18% in the past 14 days, which was higher than the 34.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.79, while its 200-day Moving Average is $11.25. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $11.37. Second resistance stands at $11.66. The third major resistance level sits at $11.86. If the price goes on to break the first support level at $10.87, it is likely to go to the next support level at $10.67. Now, if the price goes above the second support level, the third support stands at $10.38.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
With a market capitalization of 7.53 billion, the company has a total of 679,806K Shares Outstanding. Currently, annual sales are 29,050 K while annual income is -171,980 K. The company’s previous quarter sales were 9,020 K while its latest quarter income was 169,380 K.
